(Q28369047)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10402106%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

title

Statin + fibrate combination therapy fluvastatin with bezafibrate or ciprofibrate in high risk patients with vascular disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10402106%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10402106%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

author name string

J A Papadakis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10402106%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

I A Jagroop

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10402106%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

A F Winder

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10402106%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

D P Mikhailidis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10402106%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

language of work or name

English

0 references

publication date

1 June 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10402106%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cardiology

10 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10402106%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

volume

69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10402106%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10402106%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

page(s)

237-244

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10402106%20AND%20SRC:MED&resulttype=core&format=json

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

10 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900013-3

7 January 2021

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900013-3

7 January 2021

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900013-3

7 January 2021

Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease. An 8-year follow-up in the Copenhagen Male Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900013-3

7 January 2021

High-density lipoprotein cholesterol and risk of ischemic stroke mortality. A 21-year follow-up of 8586 men from the Israeli Ischemic Heart Disease Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900013-3

7 January 2021

Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Münster study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900013-3

7 January 2021

Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900013-3

7 January 2021

Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen City Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900013-3

7 January 2021

Combination drug therapy for familial combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900013-3

7 January 2021

Efficacy and safety of a combination fluvastatin-bezafibrate treatment for familial hypercholesterolemia: comparative analysis with a fluvastatin-cholestyramine combination

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900013-3

7 January 2021

Long-term safety of statin-fibrate combination treatment in the management of hypercholesterolaemia in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900013-3

7 January 2021

Effects of combined bezafibrate-simvastatin appraised in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900013-3

7 January 2021

Gemfibrozil-lovastatin therapy for primary hyperlipoproteinemias

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900013-3

7 January 2021

Rhabdomyolysis after taking atorvastatin with gemfibrozil

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900013-3

7 January 2021

Possible increased risk of rhabdomyolysis during concomitant use of simvastatin and gemfibrozil

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900013-3

7 January 2021

Fenofibrate plus simvastatin therapy versus simvastatin plus cholestyramine therapy for familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900013-3

7 January 2021

Safety and efficacy of long-term statin-fibrate combinations in patients with refractory familial combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900013-3

7 January 2021

High-dose fluvastatin and bezafibratecombination treatment for heterozygous familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900013-3

7 January 2021

Fluvastatin in familial hypercholesterolemia: a cohort analysis of the response to combination treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900013-3

7 January 2021

The Acute Rise in Plasma Fibrinogen Concentration With Exercise Is Influenced by the G- 453 -A Polymorphism of the β-Fibrinogen Gene

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900013-3

7 January 2021

Lp(a) lipoprotein in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900013-3

7 January 2021

Comparative efficacy and safety of ciprofibrate and sustained-release bezafibrate in patients with type II hyperlipidaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900013-3

7 January 2021

Ciprofibrate therapy normalises the atherogenic low-density lipoprotein subspecies profile in combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900013-3

7 January 2021

Effects of ciprofibrate on LDL metabolism in man

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900013-3

7 January 2021

Predominance of dense low-density lipoprotein particles predicts angiographic benefit of therapy in the Stanford Coronary Risk Intervention Project

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900013-3

7 January 2021

Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900013-3

7 January 2021

Fibrinogen and its relations to subclinical extracoronary and coronary atherosclerosis in hypercholesterolemic men

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900013-3

7 January 2021

Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900013-3

7 January 2021

Statins and fibrinogen

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900013-3

7 January 2021

Effect of atorvastatin on plasma fibrinogen

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900013-3

7 January 2021

Improvement of glucose tolerance by bezafibrate in non-obese patients with hyperlipidemia and impaired glucose tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900013-3

7 January 2021

Comparison of bezafibrate versus lovastatin for lowering plasma insulin, fibrinogen, and plasminogen activator inhibitor-1 concentrations in hyperlipemic heart transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900013-3

7 January 2021

Demonstration of insulin resistance in coronary artery disease documented with angiography.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900013-3

7 January 2021

Glucose tolerance status and severity of coronary artery disease in men referred to coronary arteriography

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900013-3

7 January 2021

Risk factors for acute myocardial infarction in Indians: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900013-3

7 January 2021

The effect of bezafibrate treatment on serum alkaline phosphatase isoenzyme activities

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900013-3

7 January 2021

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2899%2900013-3

7 January 2021

10.1016/S0167-5273(99)00013-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10402106%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference